SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055728
Filing Date
2021-11-09
Accepted
2021-11-09 16:12:21
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-10q_20210930.htm   iXBRL 10-Q 3211873
2 EX-10.2 annx-ex102_386.htm EX-10.2 142710
3 EX-31.1 annx-ex311_384.htm EX-31.1 20282
4 EX-31.2 annx-ex312_10.htm EX-31.2 20212
5 EX-32.1 annx-ex321_9.htm EX-32.1 14972
  Complete submission text file 0001564590-21-055728.txt   8846537

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA annx-20210930.xsd EX-101.SCH 44249
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE annx-20210930_cal.xml EX-101.CAL 55941
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE annx-20210930_def.xml EX-101.DEF 131441
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20210930_lab.xml EX-101.LAB 383925
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20210930_pre.xml EX-101.PRE 282670
11 EXTRACTED XBRL INSTANCE DOCUMENT annx-10q_20210930_htm.xml XML 1367262
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 211392277
SIC: 2834 Pharmaceutical Preparations